The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

BMC Psychiatry

Volumn 2, Issue , 2002, Pages

  Moises, Hans W ^a   Zoega, Tomas ^b   Gottesman, Irving I ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTAMIC ACID; GROWTH FACTOR; INSULIN; N METHYL DEXTRO ASPARTIC ACID; NEU DIFFERENTIATION FACTOR; NEURITE PROMOTING FACTOR; NEUROTROPHIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROLACTIN; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA;

ASTHENIA; EPIGENETICS; GENE LOCATION; GENE LOCUS; GENOTYPE PHENOTYPE CORRELATION; GLIA CELL; HEREDITY; HUMAN; HUMAN HERPESVIRUS 6; JC VIRUS; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; POSITIVE FEEDBACK; PRESYNAPTIC NERVE; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SYNAPTIC POTENTIAL;

EID: 0002820468     PISSN: 1471244X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-244X-2-8     Document Type: Review

References (209)

1. Sawa A, Snyder SH: Schizophrenia: diverse approaches to a complex disease. Science 2002, 296:692-695
2. Gottesman II: Schizophrenia Genesis: The Origins of Madness. New York: W.H. Freeman; 1991
3. Moises HW, Gottesman II: Genetics, risk and personality factors. In: Contemporary Psychiatry (Edited by: Henn F, Sartorius, H, Helmchen H, Lauter, N) Heidelberg, New York: Springer 2000, 3:47-59
4. Gottesman II: Psychopathology through a life span - genetic prism. Am Psychologist 2001, 56:867-878
5. Murray RM, Lewis SW: Is schizophrenia a neurodevelopmental disorder? Br Med J 1987, 295:681-682
6. Marenco S, Weinberger DR: The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2000, 12:501-527
7. Moises HWM: Human Genome data analyzed by an evolutionary method suggests a decrease in protein-synthesis rate as cause of schizophrenia and an increase as antipsychotic mechanism. ArXiv.org e-Print archive 2001 [http://xxx.arxiv.cornell.edu/abs/cond-mat/0110189]
8. Lewis DA, Levitt P: Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432
9. Monk CS, Webb SJ, Nelson CA: Prenatal neurobiological development: molecular mechanisms and anatomical change. Dev Neuropsychol 2001, 19:211-236
10. Webb SJ, Monk CS, Nelson CA: Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol 2001, 19:147-171
11. Lemke G: Glial control of neuronal development. Annu Rev Neurosci 2001, 24:87-105
12. Cotter DR, Pariante CM, Everall IP: Glial abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001, 55:585-595
13. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA: Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001, 98:4746-4751
14. Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, Rudolf S, Wandinger KP, Kirchner H: Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 2001, 6:445-449
15. Lara DR, Gama CS, Belmonte P-de-Abreu, Portela LV, Goncalves CA, Fonseca M, Hauck S, Souza DO: Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 2001, 35:11-14
16. Williams NM, O'Donovan MC, Owen MJ: Genome scans and microarrays: converging on genes for schizophrenia? Genome Biology 2002 2002, 3:1-1011
17. Goodman AB: Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A 1998, 95:7240-7244
18. Niculescu ABr, Kelsoe JR: Convergent functional genomics: application to bipolar disorder. Ann Med 2001, 33:263-271
19. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P: Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 2001, 6:293-301
20. Burden S, Yarden Y: Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997, 18:847-855
21. Buonanno A, Fischbach GD: Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 2001, 11:287-296
22. Song H, Stevens CF, Gage FH: Astroglia induce neurogenesis from adult neural stem cells. Nature 2002, 417:39-44
23. Haydon PG: GLIA: listening and talking to the synapse. Nat Rev Neurosci 2001, 2:185-193
24. Araque A, Parpura V, Sanzgiri RP, Haydon PG: Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999, 22:208-215
25. Morley SJ: Signal transduction mechanisms in the regulation of protein synthesis. Mol Biol Rep 1994, 19:221-231
26. Steward O, Schuman EM: Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 2001, 24:299-325
27. Schuman EM: Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 1999, 9:105-109
28. Fromm L, Burden SJ: Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. Biochemistry 2001, 40:5306-5312
29. Bezzi P, Volterra A: A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 2001, 11:387-394
30. Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L: Regulation of neuregulin signaling by PSD-95 interacting with erbB4 and CNS synapses. Neuron 2000, 26:443-455
31. Anton ES, Marchionni MA, Lee KF, Rakic P: Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997, 124:3501-3510
32. Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P, Marchionni M, Dubois-Dalcq M: Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 2001, 21:4740-4751
33. Wolpowitz D, Mason TB, Dietrich P, Mendelsohn M, Talmage DA, Role LW: Cysteine-rich domaine isoforms of the neuregulin-1 gene are required for maintenance of periphereal synapses. Neuron 2000, 25:79-91
34. Loeb JA, Hmadcha A, Fischbach GD, Land SJ, Zakarian VL: Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors. J Neurosci 2002, 22:2206-2214
35. Adlkofer K, Lai C: Role of neuregulins in glial cell development. Glia 2000, 29:104-111
36. Wang JY, Frenzel KE, Wen D, Falls DL: Transmembrane neuregulins interact with LIM kinase 1, a cytoplasmic protein kinase implicated in development of visuospatial cognition. J Biol Chem 1998, 273:20525-20534
37. Olayioye MA, Neve RM, Lane HA, Hynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000, 19:3159-3167
38. Liu Y, Ford B, Mann MA, Fischbach GD: Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neuroci 2001, 21:5660-5669
39. Sapru MK, Florance SK, Kirk C, Goldman D: Identification of a neuregulin and protein-tyrosine phosphatase response element in the nicotinic acetylcholine receptor E subunit gene: Regulatory role of an Ets transcription factor. Proc Natl Acad Sci U S A 1998, 95:1289-1294
40. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G: A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 1999, 19:2059-2068
41. Hertig CM, Kubalak SW, Wang Y, Chien KR: Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis. J Biol Chem 1999, 274:37362-37369
42. Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC, Carraway KL 3rd: Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem 2001, 276:22685-22698
43. Scheving LA, Russell WE: Insulin and heregulin-beta1 upregulate guanylyl cyclase C expression in rat hepatocytes: reversal by phosphodiesterase-3 inhibition. Cell Signal 2001, 13:665-672
44. Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, Bunge R, Godowski PJ, Sliwkowski MX, Mather JP: Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 1996, 16:2012-2019
45. Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wierman ME: Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 1999, 13:191-201
46. Goruppi S, Ruaro E, Varnum B, Schneider C: Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 1997, 17:4442-4453
47. Eilam R, Pinkas-Kramarski R, Ratzkin BJ, Segal M, Yarden Y.: Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc Natl Acad Sci U S A 1998, 95:1888-1893
48. Naeve GS, Ramakrishnan M, Kramer R, Hevroni D, Citri Y, Theill LE: Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc Natl Acad Sci U S A 1997, 94:2648-2653
49. Subramony P, Dryer SE: Neuregulins stimulate the functional expression of Ca2+-activated K+ channels in developing chicken parasympathetic neurons. Proc Natl Acad Sci U S A 1997, 94:5934-5938
50. Cameron JS, Dryer L, Dryer SE: beta-Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons. Proc Natl Acad Sci U S A 2001, 98:2832-2836
51. Thoenen H: Neurotrophins and neuronal plasticity. Science 1995, 270:593-598
52. Canossa M, Griesbeck O, Berninger B, Campana G, Kolbeck R, Thoenen H: Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci U S A 1997, 94:13279-13286
53. Otten U, Marz P, Heese K, Hock C, Kunz D, Rose-John S: Cytokines and neurotrophins interact in normal and diseased states. Ann N Y Acad Sci 2000, 917:322-330
54. Canossa M, Gartner A, Campana G, Inagaki N, Thoenen H: Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signalling pathways. Embo J 2001, 20:1640-1650
55. Alleva E, Santucci D: Psychosocial vs. "physical" stress situations in rodents and humans: role of neurotrophins. Physiol Behav 2001, 73:313-320
56. Baliga RR, Pimental DR, Zhao YY, Simmons WW, Marchionni MA, Sawyer DB, Kelly RA: NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am J Physiol 1999, 277:H2026-2037
57. Kleijn M, Welsh GI, Scheper GC, Voorma HO, Proud CG, Thomas AA: Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells. J Biol Chem 1998, 273:5536-5541
58. Wells DG, Richter JD, Fallon JR: Molecular mechanisms for activity-regulated protein synthesis in the synapto-dendritic compartment. Curr Opin Neurobiol 2000, 10:132-137
59. Kandel ER, Schwartz JH, Jessell TM: Essentials of Neural Science and Behavior. London: Prentice Hall; 1995
60. Shelly M, Pinkas-Kramarski R, Guarino BC, Waterman H, Wang LM, Lyass L, Alimandi M, Kuo A, Bacus SS, Pierce JH, Andrews GC, Yarden Y: Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 1998, 273:10496-10505
61. Gerlai R, Shinsky N, Shih A, Williams P, Winer J, Armanini M, Cairns B, Winslow J, Gao W, Phillips HS: Regulation of learning by EphA receptors: a protein targeting study. J Neurosci 1999, 19:9538-9549
62. Conover JC, Doetsch F, Garcia-Verdugo JM, Gale NW, Yancopoulos GD, Alvarez-Buylla A: Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat Neurosci 2000, 3:1091-1097
63. Wagner JP, Black IB, DiCicco-Bloom E: Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 1999, 19:6006-6016
64. Boxer AL, Moreno H, Rudy B, Ziff EB: FGF-2 potentiates Ca(2+)-dependent inactivation of NMDA receptor currents in hippocampal neurons. J Neurophysiol 1999, 82:3367-3377
65. Araujo DM, Cotman CW: Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 1993, 600:49-55
66. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC: Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285
67. Hemi R, Paz K, Wertheim N, Karasik A, Zick Y, Kanety H: Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteins. J Biol Chem 2002, 277:8961-8969
68. Carrie A, Jun L, Bienvenu T, Vinet MC, McDonell N, Couvert P, Zemni R, Cardona A, Van Buggenhout G, Frints S, et al: A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999, 23:25-31
69. Pak JH, Huang FL, Li J, Balschun D, Reymann KG, Chiang C, Westphal H, Huang KP: Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc Natl Acad Sci U S A 2000, 97:11232-11237
70. Häfner H: Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand Suppl 2000, 102:44-48
71. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F: Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001, 58:158-164
72. Beveridge WIB: The art of scientific investigation. London: Mercury; 1965
73. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Olincy A, Adler LE, Cloninger CR, Kaufmann CA, et al: Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am J Med Genet 1998, 81:308-312
74. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, et al: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997, 94:587-592
75. Williams J, McGuffin P, Nöthen M, Owen MJ: Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997, 349:1221
76. Iwata N, Ozaki N, Goldman D: Association of a 5-HT(5A) receptor polymorphism, Pro15Ser, to schizophrenia. Mol Psychiatry 2001, 6:217-219
77. Jonsson E, Brene S, Zhang XR, Nimgaonkar VL, Tylec A, Schalling M, Sedvall G: Schizophrenia and neurotrophin-alleles. Acta Psychiatr Scand 1997, 95:414-419
78. Devon RS, Anderson S, Teague PW, Muir WJ, Murray V, Pelosi A, Blackwood DH, Porteous DJ: The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol Psychiatry 2001, 6:311-314
79. Wei J, Hemmings GP: The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat Genet 2000, 25:376-377
80. Moises HW, Matthiasson P, Zoega T, Jhala G, Yang L, Gottesman II, Helgason T.: Neuregulin 1 strongly implicated as susceptibility gene for schizophrenia by allelic association study. ArXiv.org e-Print archive 2002[http://xxx.arXiv.cornell.edu/abs/cond-mat/0203527v1], [http://xxx.arXiv.cornell.edu/abs/cond-mat/0203527]
81. Dror V, Shamir E, Ghanshani S, Kimhi R, Swartz M, Barak Y, Weizman R, Avivi L, Litmanovitch T, Fantino E, et al: hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol Psychiatry 1999, 4:254-260
82. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, Lenane M, Robertson B, Wijsman EM, Rapoport JL, et al: Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A 2002, 99:3717-3722
83. Chakravarti A: A compelling genetic hypothesis for a complex disease: PRODH2/DGCR6 variation leads to schizophrenia susceptibility. Proc Natl Acad Sci U S A 2002, 99:4755-4756
84. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA, et al: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002, 11:1373-1380
85. Wang S, Barres BA: Up a notch: instructing gliogenesis. Neuron 2000, 27:197-200
86. Meller R, Harrison PJ, Elliott JM, Sharp T: In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation. J Neurosci Res 2002, 67:399-405
87. Thompson SG, Wong PT, Leong SF, McGeer EG: Regional distribution in rat brain of 1-pyrroline-5-carboxylate dehydrogenase and its localization to specific glial cells. J Neurochem 1985, 45:1791-1796
88. Druey KM, Blumer KJ, Kang VH, Kehrl JH: Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996, 379:742-746
89. Rio C, Rieff HI, Qi P, Khurana TS, Corfas G: Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 1997, 19:39-50
90. Araque A, Carmignoto G, Haydon PG: Dynamic signaling between astrocytes and neurons. Annu Rev Physiol 2001, 63:795-813
91. Freedman R, Adams CE, Leonard S: The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat 2000, 20:299-306
92. O'Donnell K, Harkes IC, Dougherty L, Wicks IP: Expression of receptor tyrosine kinase Ax1 and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 1999, 154:1171-1180
93. Florini JR, Samuel DS, Ewton DZ, Kirk C, Sklar RM: Stimulation of myogenic differentiation by a neuregulin Glial Growth Factor 2. J Biol Chem 1996, 271:12699-12702
94. Han VK: The ontogeny of growth hormone, insulin-like growth factors and sex steroids: molecular aspects. Horm Res 1996, 45:61-6
95. Nakamura YS, Hakeda Y, Takakura N, Kameda T, Hamaguchi I, Miyamoto T, Kakudo S, Nakano T, Kumegawa M, Suda T: Tyro 3 receptor tyrosine kinase and its ligan, Gas6, stimulate the function of osteoclasts. Stem Cells 1998, 16:229-238
96. Dupont A, Moeller-Jensen O: Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In: Psychiatric case registers in public health (Edited by: ten Horn GH, Giel R, Gulbinat W, Henderson JH) Amsterdam, Elsevier 1986, 229-239
97. Saku M, Tokudome S, Ikeda M, Kono S, Makimoto K, Uchimura H, Mukai A, Yoshimura T: Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol 1995, 24:366-372
98. Torrey EF, Miller J, Rawlings R, Yolken RH: Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997, 28:1-38
99. Giannoukakis N, Deal J, Paquette J, Kukuvitis A, Polychronakos C: Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun 1996, 220:1014-1019
100. Sasaki H, Ishihara K, Kato R: Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (Tokyo) 2000, 127:711-715
101. Reik W, Surani A, eds: Genomic Imprinting: Frontiers in Molecular Biology. Oxford: Oxford University Press; 1997
102. Magnaghi-Jaulin L, Ait-Si-Ali S, Harel-Bellan A: Histone acetylation in signal transduction by growth regulatory signals. Semin Cell Dev Biol 1999, 10:197-203
103. Lin W, Sanchez HB, Deerinck T, Morris JK, Ellisman M, Lee K-F: Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Natl Acad Sci U S A 2000, 97:1299-1304
104. Crayton JW, Meltzer HY: Motor endplate alterations in schizophrenic patients. Nature 1976, 264:658-659
105. Ross J-Stanton, Meltzer HY: Motor neuron branching patterns in psychotic patients. Arch Gen Psychiatry 1981, 38:1097-1103
106. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A: Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001, 58:148-517
107. Thoenen H: Neurotrophins and activity-dependent plasticity. Prog Brain Res 2000, 128:183-191
108. Frith C, Dolan RJ: The Role of Memory in the Delusions Associated with Schizophrenia. In: Memory, Brain, and Belief (Edited by: Schacter DL, Scarry E) Cambridge, MA, Harvard University Press 2000, 115-135
109. Nimgaonkar VL: Reduced fertility in schizophrenia: here to stay? Acta Psychiatr Scand 1998, 98:348-353
110. Avila M, Thaker G, Adami H: Genetic epidemiology and schizophrenia: a study of reproductive fitness. Schizophr Res 2001, 47:233-241
111. Jones S: Natural selection in humans. In: The Cambridge Encyclopedia of Human Evolution (Edited by: Jones S, Martin, R, Pilbeam, D) Cambridge, Cambridge University Press 1992, 284-287
112. Kastrukoff LF, Kim SU: Oligodendrocytes from human donors differ in resistance to herpes simplex virus 1 (HSV-1). Glia 2002, 38:87-92
113. Dubois-Dalcq M: Viral infections of neuroglial cells. In: Neuroglia (Edited by: Kettenmann H, Ransom BR) New York, Oxford, Oxford University Press 1010-1026
114. Schweighardt B, Atwood WJ: Glial cells as targets of viral infection in the human central nervous system. Prog Brain Res 2001, 132:721-735
115. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F: The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 1998, 4:486-494
116. Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, Koskiniemi M, Vaheri A, Zabriskie JB: The association of the human herpesvirus-6 and MS. Mult Scler 1999, 5:355-362
117. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, et al: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995, 92:7440-7444
118. Clark DA: Human herpesvirus 6. Rev Med Virol 2000, 10:155-173
119. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F, Girones R: Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001, 75:10290-10299
120. Major EO, Vacante DA: Human fetal astrocytes in culture support the growth of the neurotropic human polyomavirus, JCV. J Neuropathol Exp Neurol 1989, 48:425-436
121. Gordon J, Khalili K: The human polyomavirus, JCV, and neurological diseases (review). Int J Mol Med 1998, 1:647-655
122. Tretiakova A, Krynska B, Gordon J, Khalili K: Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation. J Neurosci Res 1999, 55:588-599
123. Bofill-Mas S, Pina S, Girones R: Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000, 66:238-245
124. Weiss KM, Terwilliger JD: How many diseases does it take to map a gene with SNPs? Nat Genet 2000, 26:151-157
125. Kidd JR, Pakstis AJ, Zhao H, Lu RB, Okonofua FE, Odunsi A, Grigorenko E, Tamir BB, Friedlaender J, Schulz LO, Parnas J, Kidd KK: Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet 2000, 66:1882-1899
126. Wang D, Sun F: Sample sizes for the transmission disequilibrium tests: TDT, S-TDT and 1-TDT. Commun Stat-Theory M 2000, 29:1129-1142
127. Long AD, Langley CH: The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res 1999, 9:720-731
128. Jorde LB: Linkage disequilibrium and the search for complex disease genes. Genome Res 2000, 10:1435-1444
129. Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV, Schwab SG, Williams NM, Owen MJ, Wildenauer DB, et al: No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002, 296:739-741
130. Badner JA, Gershon ES: Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411
131. Altmüller J, Palmer LJ, Fischer G, Scherb H, Wjst M: Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 2001, 69:936-950
132. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856
133. Wudarsky M, Nicolson R, Hamburger SD, Spechler L, Gochman P, Bedwell J, Lenane MC, Rapoport JL: Elevated prolactin in pediatric patients on typical and atypical antipsychotics. J Child Adolesc Psychopharmacol 1999, 9:239-245
134. Petty RG: Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999, 35 Suppl:S67-73
135. Wetzel H, Wiesner J, Hiemke C, Benkert O: Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers. J Psychiatr Res 1994, 28:461-473
136. Grunder G, Wetzel H, Schlosser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O: Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 1999, 45:89-97
137. Bench CJ, Lammertsma AA, Grasby PM, Dolan RJ, Warrington SJ, Boyce M, Gunn KP, Brannick LY, Frackowiak RS: The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography. Psychopharmacology (Berl) 1996, 124:141-147
138. Otani K, Kondo T, Kaneko S, Ishida M, Fukushima Y: Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients. Int Clin Psychopharmacol 1994, 9:287-289
139. Yazici KM, Erbas T, Yazici AH: The effect of clozapine on glucose metabolism. Exp Clin Endocrinol Diabetes 1998, 106:475-477
140. Melkersson KI, Hulting AL, Brismar KE: Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry 1999, 60:783-791
141. Melkersson KI, Hulting AL: Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents. Psychopharmacology (Berl) 2001, 154:205-212
142. Petronis A, Gottesman II, Crow TJ, DeLisi LE, Klar AJ, Macciardi F, McInnis MG, McMahon FJ, Paterson AD, Skuse D, Sutherland GR: Psychiatric epigenetics: a new focus for the new century. Mol Psychiatry 2000, 5:342-346
143. Torrey EF, Peterson MR: Slow and latent viruses in schizophrenia. Lancet 1973, 2:22-24
144. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980, 20:379-382
145. Olney JW, Newcomer JW, Farber NB: NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33:523-533
146. Antonarakis SE, Blouin JL, Pulver AE, Wolyniec P, Lasseter VK, Nestadt G, Kasch L, Babb R, Kazazian HH, Dombroski B, et al: Schizophrenia susceptibility and chromosome 6p24-22. Nat Genet 1995, 11:235-236
147. Arolt V, Lencer R, Nolte A, Müller-Myhsok B, Purmann S, Schurmann M, Leutelt J, Pinnow M, Schwinger E: Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet 1996, 67:564-579
148. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Gebhardt C, Gerhard E, Fuchs K, Sieghart W, et al: Genome scan for susceptibility loci for schizophrenia. Neuropsychobiology 2000, 42:175-182
149. Barr CL, Kennedy JL, Pakstis AJ, Wetterberg L, Sjögren B, Bierut L, Wadelius C, Wahlstrom J, Martinsson T, et al: Progress in a genome scan for linkage in schizophrenia in a large Swedish kindred. Am J Med Genet 1994, 54:51-58
150. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, et al: Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998, 20:70-73
151. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS: Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000, 288:678-82
152. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey CJ, Beshah E, Guroff JJ, et al: Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997, 43:1-8
153. Collinge J, Delisi LE, Boccio A, Johnstone EC, Lane A, Larkin C, Leach M, Lofthouse R, Owen F, et al: Evidence for a pseudo-autosomal locus for schizophrenia using the method of affected sibling pairs. Br J Psychiatry 1991, 158:624-629
154. Coon H, Jensen S, Holik J, Hoff M, Myles-Worsley M, Reimherr F, Wender P, Waldo M, Freedman R, Leppert M, et al: Genomic scan for genes predisposing to schizophrenia. Am J Med Genet 1994, 54:59-71
155. Coon H, Myles-Worsley M, Tiobech J, Hoff M, Rosenthal J, Bennett P, Reimherr F, Wender P, Dale P, Polloi A, Byerley W: Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol Psychiatry 1998, 3:521-527
156. Crow TJ, Delisi LE, Lofthouse R, Poulter M, Lehner T, Bass N, Shah T, Walsh C, Boccio-Smith A, Shields G, et al: An examination of linkage of schizophrenia and schizoaffective disorder to the pseudoautosomal region (Xp22.3). Br J Psychiatry 1994, 164:159-164
157. Dann J, DeLisi LE, Devoto M, Laval S, Nancarrow DJ, Shields G, Smith A, Loftus J, Peterson P, Vita A, et al: A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Res 1997, 70:131-143
158. DeLisi LE, Devoto M, Lofthouse R, Poulter M, Smith A, Shields G, Bass N, Chen G, Vita A, Morganti C, et al: Search for linkage to schizophrenia on the X and Y chromosomes. Am J Med Genet 1994, 54:113-121
159. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, Wellman N, Loftus J, Nanthakumar B, Razi K, et al: A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 2002, 159:803-812
160. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, Juvonen H, Varilo T, Arajarvi R, Kokko-Sahin ML, Lonnqvist J, Peltonen L: Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 2000, 9:1049-1057
161. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, et al: Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998, 81:290-295
162. Garver DL, Holcomb J, Mapua FM, Wilson R, Barnes B: Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigrees. Schizophr Res 2001, 52:145-160
163. Gill M, Vallada H, Collier D, Sham P, Holmans P, Murray R, McGuffin P, Nanko S, Owen M, Antonarakis S, et al: A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996, 67:40-45
164. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, et al: Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001, 68:661-673
165. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, Juvonen H, Kokko-Sahin ML, Vaisanen L, Mannila H, Lonnqvist J, Peltonen L: A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999, 65:1114-1124
166. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, et al: NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998, 81:282-289
167. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke
168. Lasseter VK, Pulver AE, Wolyniec PS, Nestadt G, Meyers D, Karayiorgou M, Housman D, Antonarakis S, Kazazian H, et al: Follow-up report of potential linkage for schizophrenia on chromosome 22q: Part 3. Am J Med Genet 1995, 60:172-173
169. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, Hayward NK, Crowe RR, Andreasen NC, Black DW, et al: Genome scan of schizophrenia. Am J Psychiatry 1998, 155:741-750
170. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, Pulver AE, Laurent C, Kendler KS, Walsh D, et al: Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000, 67:652-663
171. Lin MW, Curtis D, Williams N, Arranz M, Nanko S, Collier D, McGuffin P, Murray R, Owen M, Gill M, et al: Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet 1995, 5:117-126
172. Lin MW, Sham P, Hwu HG, Collier D, Murray R, Powell JF: Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Hum Genet 1997, 99:417-420
173. Lindholm E, Ekholm B, Balciuniene J, Johansson G, Castensson A, Koisti M, Nylander PO, Pettersson U, Adolfsson R, Jazin E: Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23. Am J Med Genet 1999, 88:369-377
174. Maziade M, Raymond V, Cliche D, Fournier JP, Caron C, Garneau Y, Nicole L, Marcotte P, Couture C, Simard C, et al: Linkage results on 11q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am J Med Genet 1995, 60:522-528
175. Maziade M, Bissonnette L, Rouillard E, Martinez M, Turgeon M, Charron L, Pouliot V, Boutin P, Cliche D, Dion C, et al: 6p24-22 region and major psychoses in the Eastern Quebec population. Le Groupe IREP. Am J Med Genet 1997, 74:311-318
176. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjögren B, et al: An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995, 11:321-324
177. Nanko S, Gill M, Owen M, Takazawa N, Moridaira J, Kazamatsuri H: Linkage study of schizophrenia with markers on chromosome 11 in two Japanese pedigrees. Jpn J Psychiatry Neurol 1992, 46:155-159
178. Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA, Rinard K, Foti A, Terwilliger JD, et al: Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 2001, 10:3037-3048
179. Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G, et al: Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. Am J Med Genet 1994, 54:44-50
180. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, Kimberland M, Babb R, Vourlis S, Chen H, et al: Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995, 60:252-260
181. Pulver AE, Mulle J, Nestadt G, Swartz KL, Blouin JL, Dombroski B, Liang KY, Housman DE, Kazazian HH, Antonarakis SE, et al: Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol Psychiatry 2000, 5:650-653
182. Rees MI, Fenton I, Williams NM, Holmans P, Norton N, Cardno A, Asherson P, Spurlock G, Roberts E, Parfitt E, et al: Autosome search for schizophrenia susceptibility genes in multiply affected families. Mol Psychiatry 1999, 4:353-359
183. Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R, Collier D, Murray R: Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet 2000, 96:196-201
184. SCLG 6 AND 8: Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Am J Med Genet 1996, 67:580-594
185. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D, Ebstein RP, Ackenheil M, Lerer B, Risch N, et al: Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995, 11:325-327
186. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, Lichtermann D, Minges J, Bondy B, Ackenheil M, et al: Potential linkage for schizophrenia on chromosome 22q12-q13: a replication study. Am J Med Genet 1995, 60:436-443
187. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, Lichtermann D, Ertl MA, Maier W, Wildenauer DB: Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997, 2:156-160
188. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, Segman R, Borrman M, Dreikorn B, Lichtermann D, et al: Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998, 81:302-307
189. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S, Strauss M, Segman R, Lichtermann D, Knapp M, et al: Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998, 63:1139-1152
190. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, Segman RH, Hanses C, Freymann J, Yakir A, et al: A genomewide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 2000, 5:638-649
191. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, Laval SH, Vita A, De Hert M, Cardon LR, et al: A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 1998, 81:364-376
192. Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H: Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988, 336:164-167
193. Silverman JM, Greenberg DA, Altstiel LD, Siever LJ, Mohs RC, Smith CJ, Zhou G, Hollander TE, Yang XP, Kedache M, et al: Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet 1996, 67:162-171
194. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ: Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16
195. Stöber G, Saar K, Ruschendorf F, Meyer J, Nurnberg G, Jatzke S, Franzek E, Reis A, Lesch KP, Wienker TF, Beckmann H: Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet 2000, 67:1201-1207
196. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Webb BT, Zhang J, Walsh D, et al: A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 1995, 11:287-293
197. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS: Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997, 2:148-155
198. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C, Webb BT, O'Neill FA, Walsh D, Kendler KS: A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998, 81:296-301
199. Turner WJ: Genetic markers for schizotaxia. Biol Psychiatry 1979, 14:177-206
200. Vallada HP, Gill M, Sham P, Lim LC, Nanko S, Asherson P, Murray RM, McGuffin P, Owen M, Collier D: Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet 1995, 60:139-146
201. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR, Diehl SR: Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995, 10:41-46
202. Wildenauer DB, Hallmayer J, Schwab SG, Albus M, Eckstein GN, Zill P, Honig S, Strauss M, Borrmann M, Lichtermann D, et al: Searching for susceptibility genes in schizophrenia by genetic linkage analysis. Cold Spring Harb Symp Quant Biol 1996, 61:845-850
203. Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, et al: A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet 1999, 8:1729-1739
204. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247
205. Chalifa-Caspi V, Prilusky J, Lancet D: The Unified Database. Rehovot, Israel: Weizmann Institute of Science, Bioinformatics Unit and Genome Center; 1998
206. Gottesman II, Shields J: A polygenic theory of schizophrenia. Proc Natl Acad Sci USA 1967, 58:199-205
207. Tanner JM: Human growth and development. In: The Cambridge Encyclopedia of Human Evolution (Edited by: Jones S, Martin, R, Pilbeam, D) Cambridge, Cambridge University Press 1992, 98-105
208. Chugani HT, Phelps ME, Mazziotta JC: Positron emission tomography study of human brain functional development. Ann Neurol 1987, 22:487-497
209. Cohen MR, Nagel E: An introduction to logic and scientific method. New York: Hartcourt; 1934